Figure 2.

Validated the recurrence risk model based on methylation profiles of 3 genes in the internal cohort. (a) Time-dependent receiver operating characteristic curves for predicting 1-year, 3-year, and 5-year recurrence free survival in the internal cohort. (b) Risk score distribution of DTC patients in the Train cohort. (c) Survival status of DTC patients in the internal cohort. (d) Methylation profiles of 3 genes in high risk group and low risk group by heat map analysis. (e) Kaplan-Meier survival curves for recurrence free survival. AUC: area under the curve.